Immunomedics (IMMU) Misses Q4 EPS by 6c

August 17, 2016 4:01 PM EDT
Get Alerts IMMU Hot Sheet
Trade IMMU Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment